IMUC

ImmunoCellular Therapeutics, Ltd.
IMUC

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

IMUC was delisted on the 16th of October, 2018.

Back to rankings

49 hedge funds and large institutions have $10.1M invested in ImmunoCellular Therapeutics, Ltd. in 2013 Q2 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
49
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$934K
Puts
$632K
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.05M
2
$984K
3
$938K
4
$644K
5
$427K
6
$422K
7
$391K
8
$365K
9
$352K
10
$340K
11
$323K
12
$291K
13
$267K
14
$261K
15
$179K
16
$178K
17
$176K
18
$141K
19
$130K
20
$101K
21
$97K
22
$90K
23
$89K
24
$82K
25
$78K
1
2